Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.1600 (1.93%) ($12.1600 - $12.1600) on Tue. May. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.68% (three month average) | RSI | 57 | Latest Price | $12.1600(1.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(36%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -2.84% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) IGOV(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.84% (StdDev 5.68%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.17(-0.08%) | 10 Day Moving Average | $11.92(2.01%) | 20 Day Moving Average | $11.78(3.23%) | To recent high | -10.8% | To recent low | 32.2% | Market Cap | $2.145b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |